BioInformant announced key enhancements to its targeted email lists to give life science marketers even more power to reach the inbox of their prospective customers.
Trevigen introduces a highly sensitive, quantitative and validated assay to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening.
Top medical device distributors MenkeMed in Germany and Austria and Ecce Dutoit in the Benelux, signed contract deals to distribute Allium's ureteral and biliary stents